Largest TAVI Device Study Shows Positive Patient Outcomes

Published date : 23 October 2012
Article date : 23 October 2012

Reuters reports on a press release from Medtronic which announces new findings from the medical device manufacturer's CoreValve ADVANCE Study for 1-year survival and health-related quality of life. The findings, presented this week at Transcatheter Cardiovascular Therapeutics Meeting 2012 in Miami, indicated high survival rates and improved quality of life for patients. 
The study revealed a 1 year survival at 82.1% and 1year cardiovascular survival at 88.2%. Health-related quality of life (HRQoL) measures for patients in the ADVANCE Study improved significantly at 1 and 6 months, compared with their status prior to receiving the Medtronic CoreValve System. They say that the ADVANCE study represents the largest, most rigorously collected evaluation of HRQoL findings published on transcatheter aortic valve implantation (TAVI).
Apparently, in the study, even the highest risk patients experienced significant improvements in HRQoL after TAVI.  The article goes on to say that the ADVANCE study is one of the largest multicenter TAVI trials to date, with 996 patients consecutively treated at 44 experienced TAVI centers in 12 countries. 
The CoreValve System is currently limited to investigational use in the United States.
Source: Reuters, 22 October 2012
Read the original article here
Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.